Saturn V Capital Management LP
Q1 2025 13F Holdings
- Locationaustin, TX
- Num holdings
21
- Value ($000)
$198,158
- Date Filed05/15/2025
- Form type13F-HR
- CIK0001964437
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q1 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
ASND ASCENDIS PHARMA A/S | SPONSORED ADR | 04351P101 | $31.06M | 16 % | 199,264 | ||
IRON DISC MEDICINE INC | COM | 254604101 | $25.72M | 13 % | 518,177 | ||
CGON CG ONCOLOGY INC | COM | 156944100 | $14.15M | 7 % | 577,696 | ||
XENON PHARMACEUTICALS INC | COM | 98420N105 | $13.88M | 7 % | 413,711 | ||
MERUS N V | COM | N5749R100 | $13.60M | 7 % | 323,211 | ||
MLTX MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | $13.43M | 7 % | 343,849 | ||
SNDX SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | $12.79M | 7 % | 1,041,280 | ||
CELC CELCUITY INC | COM | 15102K100 | $11.06M | 6 % | 1,093,677 | ||
COGT COGENT BIOSCIENCES INC | COM | 19240Q201 | $8.87M | 5 % | 1,480,020 | ||
PCVX VAXCYTE INC | COM | 92243G108 | $8.77M | 4 % | 232,295 |
Rows Per Page
10
- 10
- 50
- 100